Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

Chinese biopharma firm Gensciences rakes in $124m in Series A, B rounds

04 March, 2021

biopharmaceutical Gensciences Haitong Capital

Printed by Unregistered user on Sun, 24 Aug 2025 00:17:37 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Chinese clinical-stage biopharma firm Connect files for Nasdaq IPO

GL Ventures, Temasek co-lead $230m round in China's Clover Biopharmaceuticals

Read more from Greater China

Miniso’s Top Toy hits $1.3b valuation after Temasek boost

China’s food delivery wars lead to free meals, half-price designer bags